InvenireX Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.68M

  • Investors
  • 6

InvenireX General Information

Description

Developer of a molecular diagnostics platform designed to democratize and accelerate life science research. The company's platform possesses limits of detection, several orders of magnitude lower than current, commonly used diagnostic methods of detection, enabling biotech researchers to live detection of nucleic acids, ribonucleic acid, and proteins through video-feed with single-molecule precision using artificial intelligence.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • D1 Milburn House
  • Dean Street
  • Newcastle Upon Tyne NE1 1LF
  • England, United Kingdom
+44 07852
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • D1 Milburn House
  • Dean Street
  • Newcastle Upon Tyne NE1 1LF
  • England, United Kingdom
+44 07852

InvenireX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InvenireX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 15-Aug-2025 $2.68M Completed Generating Revenue
3. Early Stage VC 18-Mar-2024 Completed Product In Beta Test
2. Early Stage VC 08-Sep-2023 $506K $628K Completed Product In Beta Test
1. Accelerator/Incubator 01-Jan-2023 $122K $122K Completed Startup
To view InvenireX’s complete valuation and funding history, request access »

InvenireX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
E Ordinary
C Oridnary
E Ordinary
A5 Ordinary
A1 Ordinary
C Oridnary
A4 Ordinary
A3 Ordinary 13,817 $0.000013 $16.8 $16.8 1x $16.8 7.11%
A1 Ordinary 13,802 $0.000013 $16.8 $16.8 1x $16.8 7.1%
To view InvenireX’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InvenireX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InvenireX Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cambridge Technology Capital Fund Mezzanine Minority
Innovate UK Government
Angel (individual) Minority
DSW Ventures Venture Capital Minority
XTX Ventures Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

InvenireX FAQs

  • When was InvenireX founded?

    InvenireX was founded in 2021.

  • Where is InvenireX headquartered?

    InvenireX is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of InvenireX?

    InvenireX has 11 total employees.

  • What industry is InvenireX in?

    InvenireX’s primary industry is Discovery Tools (Healthcare).

  • Is InvenireX a private or public company?

    InvenireX is a Private company.

  • What is the current valuation of InvenireX?

    The current valuation of InvenireX is .

  • What is InvenireX’s current revenue?

    The current revenue for InvenireX is .

  • How much funding has InvenireX raised over time?

    InvenireX has raised $3.93M.

  • Who are InvenireX’s investors?

    Cambridge Technology Capital Fund, Innovate UK, , DSW Ventures, and XTX Ventures are 5 of 6 investors who have invested in InvenireX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process